- Home
- ARQT vs GTX Comparison
ARQT vs GTX Comparison
Compare ARQT & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | GTX |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARQT | GTX |
|---|---|---|
| Price | $20.69 | $33.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $34.00 | $20.40 |
| AVG Volume (30 Days) | 1.9M | ★ 3.1M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 88.79 | 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | $376,072,000.00 | ★ $3,584,000,000.00 |
| Revenue This Year | $34.85 | $4.16 |
| Revenue Next Year | $29.39 | $3.27 |
| P/E Ratio | ★ N/A | $67.91 |
| Revenue Growth | ★ 91.34 | 3.14 |
| 52 Week Low | $12.72 | $9.58 |
| 52 Week High | $31.77 | $33.38 |
Technical Indicators
Market Signals| Indicator | ARQT | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 80.21 |
| Support Level | $19.60 | $17.01 |
| Resistance Level | $24.56 | N/A |
| Average True Range (ATR) | 1.26 | 1.32 |
| MACD | -0.07 | 0.25 |
| Stochastic Oscillator | 28.34 | 89.24 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.